Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2026-05-21 16:33:59 ET · period of report 2026-05-21 · accession 0001231589-26-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-05-21 16:33 | 2026-05-21 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +8,300 | 53.5K | +18% | +$1.21M |
| DMT | 2026-05-21 16:33 | 2026-05-21 | UTHR | MAHON PAUL A | EVP, GC | S - Sale+OE | $562.82 | -8,300 | 45.2K | -16% | -$4.67M |
| DT | 2026-05-21 16:33 | 2026-05-21 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $0.00 | -8,300 | 113.9K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-21 | M | A | 300 | $146.03 | 45,472 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. |
| 2 | Common | Common Stock | 2026-05-21 | M | A | 8,000 | $146.03 | 53,472 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. |
| 3 | Common | Common Stock | 2026-05-21 | S | D | 110 | $555.72 | 53,362 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F2) This transaction was executed in multiple trades at prices ranging from $555.56 to $556.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2026-05-21 | S | D | 10 | $556.70 | 53,352 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. |
| 5 | Common | Common Stock | 2026-05-21 | S | D | 640 | $557.85 | 52,712 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. |
| 6 | Common | Common Stock | 2026-05-21 | S | D | 200 | $559.99 | 52,512 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. |
| 7 | Common | Common Stock | 2026-05-21 | S | D | 2,178 | $561.99 | 50,334 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F3) This transaction was executed in multiple trades at prices ranging from $561.31 to $562.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Common | Common Stock | 2026-05-21 | S | D | 1,326 | $562.93 | 49,008 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F4) This transaction was executed in multiple trades at prices ranging from $562.63 to $563.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 9 | Common | Common Stock | 2026-05-21 | S | D | 2,015 | $564.06 | 46,993 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F5) This transaction was executed in multiple trades at prices ranging from $563.77 to $564.755. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 10 | Common | Common Stock | 2026-05-21 | S | D | 1,251 | $565.20 | 45,742 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F6) This transaction was executed in multiple trades at prices ranging from $564.905 to $565.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 11 | Common | Common Stock | 2026-05-21 | S | D | 270 | $566.05 | 45,472 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F7) This transaction was executed in multiple trades at prices ranging from $565.91 to $566.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 12 | Common | Common Stock | 2026-05-21 | S | D | 300 | $562.50 | 45,172 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. |
| 13 | Derivative | Stock Option | 2026-05-21 | M | D | 8,300 | $0.00 | 113,940 | D | $146.03 · 2020-03-15 to 2027-03-15 | 8,300 Common Stock | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. |